Cytek Biosciences, Inc.

Annual Trend FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Total Revenue $92.8m $128.0m $164.0m $193.0m $200.5m $201.5m
Cost of Revenue $41.1m $48.8m $63.1m $83.6m $89.3m $97.0m
Gross Profit $51.7m $79.1m $101.0m $109.4m $111.1m $104.5m
Operating Expenses $38.1m $70.0m $102.8m $137.3m $131.6m $144.8m
Operating Income (Loss) $13.7m $9.2m ($1.8m) ($27.8m) ($20.5m) ($40.4m)
Additional Financial Items
Amortization of Intangible Assets $71k $334k $835k $3.3m $3.7m $3.7m
Gain (Loss) Related to Litigation Settlement ($1.0m)
Income (Loss) from Continuing Operations before Income Taxes, Domestic $14.1m ($1.9m) ($1.3m) ($16.9m) ($12.8m) ($44.5m)
Income (Loss) from Continuing Operations, Per Basic Share $0 $0 $0 ($0) ($0) ($1)
Income (Loss) from Continuing Operations, Per Diluted Share $0 $0 $0 ($0) ($0) ($1)
Investment Income, Interest $110k $49k $4.6m $6.4m $5.1m $2.2m
Undistributed Earnings (Loss) Allocated to Participating Securities, Basic ($16.2m) ($3.0m) $0 $0
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $14.4m $5.9m $1.3m ($15.7m) ($5.7m) ($29.8m)
Net Income (Loss) Attributable to Parent $19.4m $3.0m $2.5m ($12.1m) ($6.0m) ($66.5m)
Net Income (Loss) Available to Common Stockholders, Basic $3.2m $0 $2.6m ($12.1m) ($6.0m) ($66.5m)
Net Income (Loss) Attributable to Noncontrolling Interest $26k $92k $0 $0 $0
Earnings Per Share, Basic $0.11 $0.00 $0.02 ($0.09) ($0) ($1)
Earnings Per Share, Diluted $0.10 $0.00 $0.02 ($0.09) ($0) ($1)
Weighted Average Number of Shares Outstanding, Basic 29.1m 76.7m 134.5m 135.3m 130.6m 127.7m
Weighted Average Number of Shares Outstanding, Diluted 32.6m 81.5m 138.6m 135.3m 130.6m 127.7m
Other Nonoperating Income (Expense) $994k ($1.5m) $1.0m $7.8m $4.5m $8.8m
Interest Expense (non-operating) ($5.2m) $474k
Business Combination, Acquisition Related Costs $1.5m
Current Income Tax Expense (Benefit) $2.4m $4.7m $10.1m $6.5m $3.2m $3.1m
General and Administrative Expense $9.4m $20.8m $34.7m $44.0m $43.1m $58.9m
Interest Expense $333k $1.7m $2.6m $2.1m
Marketing and Advertising Expense $1.0m $1.8m $2.5m $3.4m $3.8m $4.2m
Nonoperating Income (Expense) $771k ($3.2m) $3.1m $12.1m $14.8m $10.5m
Research and Development Expense $13.7m $24.4m $34.9m $44.2m $39.4m $36.5m
Selling and Marketing Expense $15.0m $24.7m $33.2m $49.1m $49.1m $49.4m
Income Tax Expense (Benefit) ($5.0m) $2.9m ($1.2m) ($3.6m) $320k $36.7m